Loading clinical trials...

UNKNOWN

Blood Types in Children With COVID-19

ABO-Rh Blood Types and COVID-19 Infection in Children: Is There a Link?

NCT04682912•Mersin Training and Research Hospital

Summary

It is speculated that in adult patients with COVID-19 blood type A is associated with the worst outcome, while blood type O is associated with mild symptoms.To our knowledge, there has been no such a study investigated ABO and Rhesus (Rh) blood group types in children with COVID-19 infection yet. Therefore, the study aimed to examine if such a correlation exists in children infected with COVID-19.

Eligibility

Age

0 - 18 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•The study period consisted between March 2020 and December 2020
•Children with a documented positive COVID-19 nasal smear real-time reverse-transcriptase polymerase chain reaction (PCR) assay were included.

Exclusion Criteria

•Patients who had a past medical history of any chronic illness (related to respiratory, cardiology, immunology, neurology, metabolic, etc) were excluded.

Locations (1)

Mersin City Training & Research Hospital

Mersi̇n, Turkey (Türkiye)

Key Dates

Start Date

January 30, 2021

Primary Completion Date

February 1, 2021

Completion Date

February 1, 2021

Last Updated

February 3, 2021

Enrollment

2,000

ESTIMATED participants

Conditions

COVID-19 Infection

Contacts

Ali̇ Özdemi̇r, MD

CONTACT

03242251000 aliozdemir@hotmail.com

Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

NCT04491292

COVID-19 Infection

View study

RECRUITINGPHASE2

A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol

NCT06381739

COVID-19 Infection

View study

RECRUITING

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 3, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Blood Types in Children With COVID-19

Inclusion Criteria

Exclusion Criteria

Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health

Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma